Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 5/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 5/20 | 1.00 |
| ▸ | BCR | P11274 | 5/20 | 1.00 |
| ▸ | ESR1 | P03372 | 5/20 | 0.77 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.69 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.59 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | CASP3 | P42574 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.58 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.58 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | MMP3 | P08254 | 1/20 | 0.55 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17081084 | 0.94 | ABL1 (0.88) | ABL1ABCB1BCRESR1ESR2 | |
| SCHEMBL2090372 | 0.94 | ABL1 (0.88) | ABL1ABCB1BCRESR1ESR2 | |
| SCHEMBL18675344 | 0.90 | ABL1 (0.82) | ABL1ABCB1BCRESR1ESR2 | |
| SCHEMBL187833 | 0.87 | ESR1 (1.00) | ABL1ABCB1BCRESR1ESR2 | |
| SCHEMBL920655 | 0.87 | ESR1 (1.00) | ABL1ABCB1BCRESR1ESR2 | |
| SCHEMBL24617945 | 0.87 | ESR1 (1.00) | ABL1ABCB1BCRESR1ESR2 | |
| SCHEMBL2830166 | 0.87 | ABL1 (0.77) | ABL1ABCB1BCRESR1ESR2 | |
| SCHEMBL6292004 | 0.83 | ESR1 (1.00) | ABL1ABCB1BCRESR1ESR2 | |
| Phloroglucinol SCHEMBL11130971 | 0.83 | ALDH1A1 (0.73) | ABL1ABCB1BCRESR1ESR2 | |
| Hydroquinone SCHEMBL5712110 | 0.83 | ESR1 (1.00) | ABL1ABCB1BCRESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2998335-B1 | METHOD FOR PRODUCING BIPHENYL-SKELETON-CONTAINING EPOXY RESIN | DAINIPPON INK & CHEMICALS (JP) | 2018-06-13 | — | — | EP | claimed |
| US-20170342194-A1 | METHOD FOR PRODUCING BIPHENYL-SKELETON-CONTAINING EPOXY RESIN | DAINIPPON INK & CHEMICALS (JP) | 2017-11-30 | — | — | US | claimed |
| US-20160083504-A1 | METHOD FOR PRODUCING BIPHENYL-SKELETON-CONTAINING EPOXY RESIN | DIC CORPORATION (JP) | 2016-03-24 | — | — | US | claimed |
| EP-2998335-A1 | METHOD FOR PRODUCING BIPHENYL-SKELETON-CONTAINING EPOXY RESIN | DIC Corporation (JP) | 2016-03-23 | — | — | EP | claimed |
| CN-111526873-B | For modulating microbial colonization substituted diphenylacetylenes of (2) | 生物曼迪克斯有限责任公司 | 2025-03-04 | — | — | CN | disclosed |
| US-20250043319-A1 | BIOSYNTHESIS OF CYCLOLAVANDULYL DERIVATIVES OF AROMATIC COMPOUNDS | INVIZYNE TECHNOLOGIES, INC. (US) | 2025-02-06 | — | — | US | disclosed |
| WO-2023205404-A2 | BIOSYNTHESIS OF CYCLOLAVANDULYL DERIVATIVES OF AROMATIC COMPOUNDS | INVIZYNE TECHNOLOGIES, INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| CN-114316510-A | Method for preparing sulfonic group-containing bimetallic composite polymer nano material | 江西师范大学 | 2022-04-12 | — | — | CN | disclosed |
| EP-3165549-B1 | EPOXY RESIN COMPOSITION FOR ELECTRONIC MATERIAL, CURED PRODUCT THEREOF AND ELECTRONIC MEMBER | DAINIPPON INK & CHEMICALS (JP) | 2021-06-16 | — | — | EP | disclosed |
| CN-111484727-B | Wide-pH-range underwater self-repairing topological interlocking network and preparation method and application thereof | 中山大学 | 2021-04-20 | — | — | CN | disclosed |
| CN-111484727-A | Wide-pH-range underwater self-repairing topological interlocking network and preparation method and application thereof | 中山大学 | 2020-08-04 | — | — | CN | disclosed |
| EP-2998335-B1 | METHOD FOR PRODUCING BIPHENYL-SKELETON-CONTAINING EPOXY RESIN | DAINIPPON INK & CHEMICALS (JP) | 2018-06-13 | — | — | EP | disclosed |
| US-7125428-B2 | 1,3-Dihydroxybenzene derivatives and colorants containing said compounds | WELLA AG (DE) | 2006-10-24 | — | — | US | disclosed |
| EP-1392673-A2 | 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS | Wella Aktiengesellschaft (DE) | 2004-03-03 | — | — | EP | disclosed |
| US-20040016063-A1 | 1,3-Dihydroxybenzene derivatives and colorants containing said compounds | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2004-01-29 | — | — | US | disclosed |
| WO-2002096901-A2 | 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS | WELLA AKTIENGESELLSCHAFT (DE) | 2002-12-05 | — | — | WO | disclosed |
| US-5512059-A | DYEING POLYUREHTANE ELASTIC FIBERS INCLUDING CHLORINE-INDUCED DEGRADATION INHIBITORS THAT DO NO ELUTE OUT | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1996-04-30 | — | — | US | disclosed |
| US-5456960-A | A multicomponent yarn comprising a polyurethane elastic fiber containing one or more chlorination resistant inhibitors selected from the group consisting of oxides and hydroxides of magnesium, zinc, aluminum and hydrotalcite | TOYO BOSEKI KABUSHIHI KAISHA (JP) | 1995-10-10 | — | — | US | disclosed |
| EP-0489395-B1 | Dyed mixed knit fabric and method for its manufacture | TOYO BOSEKI (JP) | 1995-09-27 | — | — | EP | disclosed |
| EP-0489395-A1 | Dyed mixed knit fabric and method for its manufacture | Toyo Boseki Kabushiki Kaisha (JP) | 1992-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040016063-A1 | 1,3-Dihydroxybenzene derivatives and colorants containing said compounds | KRT18, DSP, COL1A1 | ABL1 2506/4885ABCB1 860/4885BCR 1896/4885 |
| US-20170342194-A1 | METHOD FOR PRODUCING BIPHENYL-SKELETON-CONTAINING EPOXY RESIN | EPHX2, EPHX1, PAH | ABL1 1263/4885ABCB1 2931/4885BCR 204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.